Trump's push for lower drug prices is just asking Big Pharma to make less moneyByKevin RyanPublishedMay 12, 2025
Stocks close strong ahead of Google earnings even as China throws cold water on U.S. trade talksByCatherine BaabUpdatedApril 24, 2025
Pope Francis dies at 88. Here are 5 companies in his 'Inclusive Capitalism' groupByKevin WilliamsUpdatedApril 21, 2025
Google, Tesla, and IBM earnings lead a make-or-break week for stocksByCatherine BaabPublishedApril 20, 2025
8 key drug patents expiring soon — and what it means for the marketByBruce GilPublishedMarch 24, 2025
Big Pharma wants to bring back a tax break that could save it $15 billionByBruce GilPublishedMarch 6, 2025
What Walmart and 13 other companies have said about Trump's tariffsByWilliam GavinUpdatedMarch 3, 2025
Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundupByBruce GilPublishedFebruary 7, 2025
The Trump administration promises 'greater transparency' in drug price negotiationsByBruce GilPublishedJanuary 29, 2025
After Nvidia CEO's quantum computing forecast, strategist says 'good luck' to investorsByAndy MillsPublishedJanuary 8, 2025
A non-opioid pain med, a COVID-flu shot combo, and more: 7 drug launches to watch in 2025ByBruce GilPublishedOctober 25, 2024
Kamala Harris just got endorsements from 88 business leaders, ranging from Yelp's CEO to Magic JohnsonByWilliam GavinUpdatedSeptember 6, 2024
Everything to know about the 10 drugs in the first Medicare price negotiationsByBruce GilPublishedSeptember 3, 2024
